Tag rituximab [48 articles] Export Sort

Recent papers classified by the tag rituximab.

Hide details

	Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study [My Copy] Nephrol. Dial. Transplant., Vol. 24, No. 7. (1 July 2009), pp. 2157-2160. by John N. Boletis, Smaragde Marinaki, Chryssanthe Skalioti, Sofia S. Lionaki, Aliki Iniotaki, Petros P. Sfikakis posted to sle rituximab by gawlik on 2009-12-21 10:25:36 as
	Role of Rituximab Therapy in Glomerulonephritis [My Copy] J Am Soc Nephrol (17 September 2008), ASN.2008070786. by David Jayne posted to rituximab gn by guhjy on 2009-11-14 03:36:41 as
	Mécanismes de l’action des anticorps monoclonaux anti-CD20 et surveillance biologique de leurs effets☆ [My Copy] Revue du Rhumatisme (28 July 2009) by Yves Renaudineau, Valérie Devauchelle-Pensec, Catherine Hanrotel, Jacques-Olivier Pers, Alain Saraux, Pierre Youinou posted to rituximab by Yrenaudi on 2009-09-29 08:52:11 as
	Rituximab in severe pemphigus. [My Copy] Annals of the New York Academy of Sciences, Vol. 1173 (September 2009), pp. 683-691. by Enno Schmidt, Matthias Goebeler, Detlef Zillikens posted to rituximab pemphigus by animalderm on 2009-09-22 19:19:32 as
	Nephrotic syndrome and rituximab: facts and perspectives. [My Copy] Pediatric nephrology (Berlin, Germany), Vol. 24, No. 8. (August 2009), pp. 1433-1438. by Dieter Haffner, Dagmar-Christiane C. Fischer posted to rituximab gn by guhjy on 2009-09-07 03:32:38 as
	Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome. [My Copy] Clinical journal of the American Society of Nephrology : CJASN, Vol. 4, No. 3. (March 2009), pp. 579-587. by Catherine Melander, Marion Sallée, Pierre Trolliet, et al.Sophie Candon, Xavier Belenfant, Eric Daugas, Phillipe Rémy, Virginie Zarrouk, Evangéline Pillebout, Christian Jacquot, Jean-Jacques J. Boffa, Alexandre Karras, Virginie Masse, Philippe Lesavre, Caroline Elie, Isabelle Brocheriou, Bertrand Knebelmann, Laure-Hélène H. Noël, Fadi Fakhouri posted to sle rituximab cd20 by guhjy on 2009-09-07 03:31:59 as
	Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. [My Copy] Autoimmunity reviews (26 August 2009) by Thomas Dörner, David Isenberg, David Jayne, et al.Heinz Wiendl, Detlef Zillikens, Gerd Burmester, on behalf of the International Roundtable on B cells as Therapeutic Target for Intervention posted to rituximab cd20 by guhjy on 2009-09-07 03:27:46 as
	B-cell-directed therapies for autoimmune disease. [My Copy] Nature reviews. Rheumatology, Vol. 5, No. 8. (August 2009), pp. 433-441. by Thomas Dörner, Andreas Radbruch, Gerd R. Burmester posted to rituximab cd20 by guhjy on 2009-09-07 03:26:31 as
	Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy. [My Copy] Clinical and experimental immunology, Vol. 157, No. 2. (August 2009), pp. 191-197. by M. J. Leandro, I. de la Torre posted to rituximab cd20 by guhjy on 2009-09-07 03:26:27 as
	B-cell depletion in autoimmune diseases. Advances in autoimmunity. [My Copy] Autoimmunity reviews, Vol. 8, No. 7. (June 2009), pp. 585-590. by Renato Guzman Moreno posted to rituximab cd20 by guhjy on 2009-09-07 03:25:57 as along with 1 person VGreiff
	Monoclonal antibodies for podocytopathies: rationale and clinical responses. [My Copy] Nature reviews. Nephrology, Vol. 5, No. 6. (June 2009), pp. 337-348. by Maddalena Marasà, Jeffrey B. Kopp posted to rituximab podocyte cd20 by guhjy on 2009-09-07 03:25:38 as
	Targeting the B cell in vasculitis. [My Copy] Pediatric nephrology (Berlin, Germany), Vol. 24, No. 7. (July 2009), pp. 1267-1275. by Michael Walsh, David Jayne posted to vasculitis rituximab cd20 by guhjy on 2009-09-07 03:25:00 as
	Use of rituximab in patients with systemic lupus erythematosus: an update. [My Copy] Autoimmunity reviews, Vol. 8, No. 4. (February 2009), pp. 343-348. by Mario García-Carrasco, Mario Jiménez-Hernández, Ricardo O. Escárcega, et al.Claudia Mendoza-Pinto, Claudio Galarza-Maldonado, Manuel Sandoval-Cruz, Leticia Zamudio-Huerta, Aurelio López-Colombo, Ricard Cervera posted to sle rituximab cd20 by guhjy on 2009-09-07 03:15:09 as
	Rituximab therapy for membranous nephropathy: a systematic review. [My Copy] Clinical journal of the American Society of Nephrology : CJASN, Vol. 4, No. 4. (April 2009), pp. 734-744. by Andrew S. Bomback, Vimal K. Derebail, Julie G. McGregor, Abhijit V. Kshirsagar, Ronald J. Falk, Patrick H. Nachman posted to rituximab mn cd20 by guhjy on 2009-09-07 03:14:11 as
	Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. [My Copy] The Journal of pediatrics, Vol. 155, No. 1. (July 2009), pp. 136-139. by K. J. Donnithorne, T. P. Atkinson, C. H. Hinze, et al.J. B. Nogueira, S. A. Saeed, D. J. Askenazi, T. Beukelman, R. Q. Cron posted to hsp rituximab by Amazoness on 2009-07-07 10:41:25 as
	Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan. [My Copy] Leukemia research, Vol. 29, No. 6. (June 2005), pp. 679-683. by S. Modak, G. Koehne, A. Vickers, R. J. O'Reilly, N. K. Cheung posted to beta-glucan cancer lymphoma mab monoclonalantibodies rituximab by holympus on 2009-04-26 11:10:53 as
	B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. [My Copy] Expert opinion on biological therapy, Vol. 7, No. 7. (July 2007), pp. 1061-1078. by C. H. Nielsen, D. El Fassi, H. C. Hasselbalch, K. Bendtzen, L. Hegedüs posted to autoimmunity bcell rituximab by ajaymalik on 2009-03-16 17:36:25 as
	B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. [My Copy] The New England journal of medicine, Vol. 358, No. 7. (14 February 2008), pp. 676-688. by S. L. Hauser, E. Waubant, D. L. Arnold, et al.T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, A. Langer-Gould, C. H. Smith, posted to autoimmunity bcell ms rituximab by ajaymalik on 2009-03-16 17:31:52 as along with 1 person djmonstermo
	From the bench to the bedside: ways to improve rituximab efficacy. [My Copy] Blood, Vol. 104, No. 9. (1 November 2004), pp. 2635-2642. by G. Cartron, H. Watier, J. Golay, P. Solal-Celigny posted to rituximab by rfrousse on 2009-02-15 14:24:02 as along with 1 person djmonstermo
	CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [My Copy] The New England journal of medicine, Vol. 346, No. 4. (24 January 2002), pp. 235-242. by B. Coiffier, E. Lepage, J. Briere, et al.R. Herbrecht, H. Tilly, R. Bouabdallah, P. Morel, E. Van Den Neste, G. Salles, P. Gaulard, F. Reyes, P. Lederlin, C. Gisselbrecht posted to rituximab by rfrousse on 2009-02-15 14:23:31 as along with 1 person djmonstermo
	Tumor burden influences exposure and response to rituximab: pharmacokinetic - pharmacodynamic modelling using a syngeneic bioluminescent murine model expressing human CD20. [My Copy] Blood (24 November 2008) by David Dayde, David Ternant, Marc Ohresser, et al.Stephanie Lerondel, Sabrina Pesnel, Herve Watier, Alain Le Pape, Pierre Bardos, Gilles Paintaud, Guillaume Cartron posted to rituximab by rfrousse on 2009-02-15 14:16:39 as
	CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy [My Copy] Blood, Vol. 112, No. 10. (15 November 2008), pp. 3982-3988. by Michael N. Dworzak, Angela Schumich, Dieter Printz, et al.Ulrike Potschger, Zvenyslava Husak, Andishe Attarbaschi, Giuseppe Basso, Giuseppe Gaipa, Richard Ratei, Georg Mann, Helmut Gadner posted to rituximab by rfrousse on 2009-02-15 14:15:51 as along with 1 person rajeevsat
	Cerebrospinal fluid diffusion of Zevalin after high-activity treatment and stem cell support in a patient affected by diffuse large B-cell non-Hodgkin's lymphoma with central nervous system involvement [My Copy] Annals of Oncology, Vol. 16, No. 10. (October 2005), pp. 1710-1711. by P. F. Ferrucci, A. Vanazzi, G. Tesoriere, et al.M. Ferrari, M. Bartolomei, P. Rocca, M. Cremonesi, G. Paganelli, G. Martinelli posted to pcnsl rituximab zavalin by eisei on 2009-01-14 06:15:55 as
	In Reply [My Copy] J Clin Oncol, Vol. 25, No. 28. (1 October 2007), pp. 4509-4511. by James Rubenstein, Lauren Abrey, Ranjana Advani, Marc Shuman, Tony Tsai, Joan O'Brien posted to intra-csf pcnsl rituximab by eisei on 2009-01-14 06:13:01 as
	Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab [My Copy] Cancer Science, Vol. 97, No. 1. (2006), pp. 80-83. by Akiyoshi Takami, Tomoe Hayashi, Daisuke Kita, Ryosei Nishimura, Hidesaku Asakura, Shinji Nakao posted to pcnsl rituximab by eisei on 2009-01-14 05:00:06 as
	Rituximab and intravenous immune globulin for desensitization during renal transplantation. [My Copy] The New England journal of medicine, Vol. 359, No. 3. (17 July 2008), pp. 242-251. by A. A. Vo, M. Lukovsky, M. Toyoda, et al.J. Wang, N. L. Reinsmoen, C. H. Lai, A. Peng, R. Villicana, S. C. Jordan posted to ivig rituximab by djmonstermo on 2008-07-20 02:23:35 as
	A single cycle of rituximab for the treatment of severe pemphigus. [My Copy] The New England journal of medicine, Vol. 357, No. 6. (9 August 2007), pp. 545-552. by P. Joly, H. Mouquet, J. C. Roujeau, et al.M. D'Incan, D. Gilbert, S. Jacquot, M. L. Gougeon, C. Bedane, R. Muller, B. Dreno, M. S. Doutre, E. Delaporte, C. Pauwels, N. Franck, F. Caux, C. Picard, E. Tancrede-Bohin, P. Bernard, F. Tron, M. Hertl, P. Musette posted to rituximab by djmonstermo on 2008-07-20 02:22:03 as
	Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. [My Copy] N Engl J Med, Vol. 355, No. 17. (26 October 2006), pp. 1772-1779. by A. R. Ahmed, Z. Spigelman, L. A. Cavacini, M. R. Posner posted to ivig rituximab by djmonstermo on 2008-07-20 02:21:22 as along with 1 person dbs
	Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. [My Copy] N Engl J Med, Vol. 350, No. 25. (17 June 2004), pp. 2572-2581. by J. C. Edwards, L. Szczepanski, J. Szechinski, et al.A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, T. Shaw posted to rituximab by djmonstermo on 2008-07-19 23:00:40 as along with 1 person goo
	Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. [My Copy] Arthritis and rheumatism, Vol. 48, No. 6. (June 2003), pp. 1484-1492. by G. J. Silverman, S. Weisman posted to rituximab by djmonstermo on 2008-07-19 23:00:16 as
	Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. [My Copy] Blood, Vol. 101, No. 10. (15 May 2003), pp. 3857-3861. by M. Zecca, B. Nobili, U. Ramenghi, et al.S. Perrotta, G. Amendola, P. Rosito, M. Jankovic, P. Pierani, P. De Stefano, M. R. Bonora, F. Locatelli posted to rituximab by djmonstermo on 2008-07-19 22:59:14 as
	Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. [My Copy] Blood, Vol. 98, No. 4. (15 August 2001), pp. 952-957. by R. Stasi, A. Pagano, E. Stipa, S. Amadori posted to rituximab by djmonstermo on 2008-07-19 22:58:19 as
	Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 16, No. 8. (August 1998), pp. 2825-2833. by P. McLaughlin, A. J. Grillo-López, B. K. Link, et al.R. Levy, M. S. Czuczman, M. E. Williams, M. R. Heyman, I. Bence-Bruckler, C. A. White, F. Cabanillas, V. Jain, A. D. Ho, J. Lister, K. Wey, D. Shen, B. K. Dallaire posted to rituximab by djmonstermo on 2008-07-19 22:57:58 as
	Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. [My Copy] Blood, Vol. 99, No. 4. (15 February 2002), pp. 1486-1488. by S. L. Goldberg, A. L. Pecora, R. S. Alter, et al.M. S. Kroll, S. D. Rowley, S. E. Waintraub, K. Imrit, R. A. Preti posted to rituximab by djmonstermo on 2008-07-19 21:34:33 as
	Rituximab: mechanism of action and resistance. [My Copy] Seminars in oncology, Vol. 29, No. 1 Suppl 2. (February 2002), pp. 2-9. by D. G. Maloney, B. Smith, A. Rose posted to rituximab by djmonstermo on 2008-07-19 21:33:13 as
	An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 14, No. 4. (April 2003), pp. 520-535. by J. Boye, T. Elter, A. Engert posted to rituximab by djmonstermo on 2008-07-19 21:32:51 as
	Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. [My Copy] Blood, Vol. 83, No. 2. (15 January 1994), pp. 435-445. by M. E. Reff, K. Carner, K. S. Chambers, et al.P. C. Chinn, J. E. Leonard, R. Raab, R. A. Newman, N. Hanna, D. R. Anderson posted to rituximab by djmonstermo on 2008-07-19 21:32:39 as
	Intraventricular and Intravenous Treatment of a Patient with Refractory Primary CNS Lymphoma using Rituximab [My Copy] Journal of Neuro-Oncology, Vol. 59, No. 3. (2002), pp. 213-216. by H. Pels, H. Schulz, O. Manzke, E. Hom, A. Thall, A. Engert posted to pcnsl rituximab by eisei on 2008-06-23 08:45:45 as
	Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab. [My Copy] Journal of neuro-oncology, Vol. 59, No. 3. (September 2002), pp. 213-216. by H. Pels, H. Schulz, O. Manzke, E. Hom, A. Thall, A. Engert posted to pcnsl rituximab by eisei on 2008-06-21 12:01:03 as
	Preparation and biodistribution of [67Ga]-DTPA-rituximab in normal rats [My Copy] Journal of Radioanalytical and Nuclear Chemistry, Vol. 274, No. 1. (17 October 2007), pp. 1-5. by A. Jalilian, L. Mirsadeghi, R. Haji-Hosseini posted to gallium rituximab by eisei on 2008-06-21 11:41:47 as
	Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide [My Copy] Neurology, Vol. 63, No. 5. (14 September 2004), pp. 901-903. by Roelien H. Enting, Alexis Demopoulos, Lisa M. Deangelis, Lauren E. Abrey posted to pcnsl rituximab temozolomide by eisei on 2008-06-20 20:20:16 as
	Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 24, No. 27. (20 September 2006), pp. 4418-4425. by M. F. Leahy, J. F. Seymour, R. J. Hicks, J. H. Turner posted to rituximab by eisei on 2008-06-02 17:57:35 as
	Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature. [My Copy] Onkologie, Vol. 26, No. 4. (August 2003), pp. 351-354. by H. Pels, H. Schulz, U. Schlegel, A. Engert posted to pcnsl rituximab by eisei on 2008-05-26 12:01:39 as
	Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 11. (10 April 2007), pp. 1350-1356. by J. L. Rubenstein, J. Fridlyand, L. Abrey, et al.A. Shen, J. Karch, E. Wang, S. Issa, L. Damon, M. Prados, M. McDermott, J. O'Brien, C. Haqq, M. Shuman posted to pcnsl intrathecal lymphoma rituximab by eisei on 2008-05-01 13:48:00 as
	Rituximab treatment of idiopathic membranous nephropathy. [My Copy] Kidney Int, Vol. 73, No. 1. (January 2008), pp. 117-125. by F. C. Fervenza, F. G. Cosio, S. B. Erickson, et al.U. Specks, A. M. Herzenberg, J. J. Dillon, N. Leung, I. M. Cohen, D. N. Wochos, E. Bergstralh, M. Hladunewich, D. C. Cattran posted to mn rituximab by yavanna on 2008-03-31 13:49:49 as
	Anti-CD20 (rituximab) treatment improves atopic eczema [My Copy] Journal of Allergy and Clinical Immunology, Vol. 121, No. 1. (January 2008), pp. 122-128. by Dagmar Simon, Susanne Hosli, Ganna Kostylina, Nikhil Yawalkar, Hans-Uwe Simon posted to atopic dermatitis rituximab by mishibas on 2008-02-07 13:56:24 as
	B cell targeted therapies: safety considerations. [My Copy] J Rheumatol Suppl, Vol. 77 (May 2006), pp. 18-23. by A. F. Kavanaugh posted to rituximab cell b by sfedson on 2007-01-15 16:38:53 as
	The emerging role of rituximab in organ transplantation [My Copy] Transplant International, Vol. 19, No. 8. (August 2006), pp. 621-628. by Becker, T. Yolanda, Samaniego-Picota, Milagros, Sollinger, W. Hans posted to rituximab rejection immunosuppression humoral by sfedson on 2007-01-15 16:04:04 as along with 1 person brainsman2000

Note: You may cite this page as: http://www.citeulike.org/tag/rituximab

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

cd20	10
pcnsl	8
rheumatoid-arthritis	4
sle	3
autoimmunity	2
b-cell	2
bcell	2
gn	2
ivig	2
lymphoma	2
mn	2
all	1
anemia	1
anti-tumor-necrosis-factor	1
aplastic	1
atopic	1
b	1
beta-glucan	1
cancer	1
cell	1
dermatitis	1
disease	1
gallium	1
hsp	1
humoral	1
immunosuppression	1
intra-csf	1
intrathecal	1
mab	1
methotrexate	1
monoclonalantibodies	1
ms	1
pemphigus	1
podocyte	1
rejection	1
t-cell	1
t-cells	1
temozolomide	1
thalidomide	1
vasculitis	1
waldenstroms	1
zavalin	1

Tag rituximab [48 articles] Export Sort

Related Tags